Last reviewed · How we verify
NCT04734743
Muscle Strength, Functional Capacity, Respiratory Function and Quality Of Life In Cystic Fibrosis Patients
NA trial testing cystic fibrosis in Cystic Fibrosis in 63 participants. Completed in 15 November 2016.
1 November 2016
Quick facts
| Lead sponsor | Cagtay Maden |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 63 |
| Start date | 1 May 2016 |
| Primary completion | 1 November 2016 |
| Estimated completion | 15 November 2016 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- cystic fibrosis
Conditions studied
- Cystic Fibrosis — all drugs for Cystic Fibrosis →
- Muscle Strength — all drugs for Muscle Strength →
- Pulmonary Function — all drugs for Pulmonary Function →
- Functional Capacity — all drugs for Functional Capacity →
Sponsor
Cagtay Maden
Who can join
Adults 6 to 15, any sex, with Cystic Fibrosis or Muscle Strength. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was designed to investigate the relationship between upper extremity muscle strength and endurance, functional capacity, and quality of life child and adolescent with cystic fibrosis
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04734743
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cystic Fibrosis
Currently open trials in the same condition.
- NCT07437105 — Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants · Phase 1 · recruiting
- NCT07283770 — Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants · Phase 1 · recruiting
- NCT07274631 — A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine · recruiting
- NCT06810167 — Assessing Tenapanor as a Treatment of CF-related Constipation. · Phase 3 · recruiting
- NCT06962852 — A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI · Phase 1, PHASE2 · active not recruiting
Other Cagtay Maden trials
Trials by the same sponsor.
- NCT04226677 — The Effects of Video Based Training and Aerobic Exercise Training in Individuals With Internet Gaming Disorder · NA · completed
- NCT04253821 — Relationship Between Head Posture Muscles, Pulmonary Capacity and Functional Capacity: a Myotonometric Assessment · NA · completed
- NCT04860557 — Comparison of the Dual Task, Cognitive Skills and Physical Activity With Problematic Game Players and Control Subjects · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04734743 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cagtay Maden
- Last refreshed: 18 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04734743.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing